These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13374955)

  • 1. [Hypocholesterolemic and choleraetic activity in the rat antiphenyl phenylethylacetic acid (2-phenyl butyric acid)].
    COTTET J; REDEL J; SALESSE J; TRICAUD ME
    C R Hebd Seances Acad Sci; 1956 Sep; 243(13):926-8. PubMed ID: 13374955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypocholesterolemic effect of phenylethylacetic acid].
    FRANZINI D
    Policlinico Med; 1956; 63(1):12-37. PubMed ID: 13310275
    [No Abstract]   [Full Text] [Related]  

  • 3. The hypocholesterolemic effect of phenylethylacetic acid amide in hypercholesterolemic atherosclerotic patients.
    ROSSI B; RULLI V
    Am Heart J; 1957 Feb; 53(2):277-83. PubMed ID: 13394527
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of treatment with methylnaphthoquinone & phenylethylacetic acid on the development of rat Galliera rat sarcoma].
    MONTINI T; PRUSSIA G
    Tumori; 1957; 43(1):74-82. PubMed ID: 13433849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypocholesterolemic activity of the combination of ethyl-p-chlorophenoxyisobutyrate and extractive sulfomucopolysaccharide].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1968 May; 23(5):256-62. PubMed ID: 4238576
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of liver cholesterol biosynthesis by butyric acid derivatives.
    Giorgini D; Porcellati G
    Farmaco Sci; 1969 Apr; 24(4):392-401. PubMed ID: 5772128
    [No Abstract]   [Full Text] [Related]  

  • 7. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypocholesterolemic effect of dietary fiber: relation to intestinal fermentation and bile acid excretion.
    Kishimoto Y; Wakabayashi S; Takeda H
    J Nutr Sci Vitaminol (Tokyo); 1995 Feb; 41(1):151-61. PubMed ID: 7616321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new hypocholesterolemia-inducing drug].
    LOEPER J
    Presse Med (1893); 1956 Sep; 64(66):1513. PubMed ID: 13379269
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism underlying the hypocholesterolemic effect of chronic fish oil feeding in rats is not due to increased excretion of dietary cholesterol.
    Bravo E; Cantafora A; DeLuca V; Tripodi M; Avella M; Botham KM
    Atherosclerosis; 1998 Aug; 139(2):253-63. PubMed ID: 9712331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mode of action of beta-benzal butyric acid, an hypocholesterolemic drug, in affecting mitochondrial respiration.
    Speranza ML; Gaiti A; Nessi R; Binaglia L; Porcellati G
    Biochem Pharmacol; 1971 Sep; 20(9):2477-84. PubMed ID: 4355784
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a hydrocholeretic agent (Zanchol) on sterol metabolism in rats.
    Raicht RF; Cohen BI; Eliav BB; Mosbach EH; Zimmon DS
    Gastroenterology; 1977 Mar; 72(3):507-9. PubMed ID: 556391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of butyric acid derivatives on membrane-bound and soluble hydroxymethylglutaryl coenzyme A reductase of rat liver.
    Gaiti A; Nessi R; Speranza ML; Montanini I; Porcellati G
    Arch Int Physiol Biochim; 1971 Aug; 79(3):555-63. PubMed ID: 4107874
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipid responses to ethyl-p-chlorophenoxyisobutyrate with different dietary fats.
    Kokatnur MG; Malcom GT; Martinez RD
    Metabolism; 1969 Jan; 18(1):73-80. PubMed ID: 5764810
    [No Abstract]   [Full Text] [Related]  

  • 15. The hypocholesterolemic effect of phenyramidol.
    Schrogie JJ
    Clin Pharmacol Ther; 1966; 7(6):723-6. PubMed ID: 5918008
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory action of cyclobutyrol on the secretion of biliary cholesterol and phospholipids.
    Monte MJ; Parslow RA; Coleman R
    Biochem J; 1990 Feb; 266(1):165-71. PubMed ID: 2310370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evaluation of an orally active combination of androsterone with ethyl chlorophenoxy-isobutyrate.
    THROP JM
    Lancet; 1962 Jun; 1(7243):1323-6. PubMed ID: 14037855
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of biliary cholesterol and phospholipid secretion during cyclobutyrol-induced hydrocholeresis.
    Monte MJ; Cava F; Esteller A; Jimenez R
    Biochem J; 1989 Oct; 263(2):513-8. PubMed ID: 2574569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats.
    Levrat MA; Favier ML; Moundras C; Rémésy C; Demigné C; Morand C
    J Nutr; 1994 Apr; 124(4):531-8. PubMed ID: 8145075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of 1,3-propanediol bis (alpha-p-chlorophenoxyisobutyrate) (CLY-503) on cholesterol biosynthesis in the rat].
    Nakanishi M; Imamura H; Matsui E; Kato Y
    Yakugaku Zasshi; 1970 Mar; 90(3):267-71. PubMed ID: 5464155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.